Cleveland Biolabs, Inc. (CBLI) Posts In-Line Q1 Loss of 15c/Share

Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q1 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $931 thousand versus the consensus estimate of $3.5 million.

For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
• LTC Properties (LTC) PT Raised to $52 at RBC Capital